vinpocetine has been researched along with Delayed Effects, Prenatal Exposure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Golani, LK; Luhach, K; Sharma, B; Sharma, N; Singh, B | 1 |
| Kulkarni, GT; Luhach, K; Sharma, B; Singh, VP | 1 |
| Catlin, N; Cunny, H; Foster, P; McIntyre, B; Miller-Pinsler, L; Mylchreest, E; Sutherland, V; Waidyanatha, S | 1 |
3 other study(ies) available for vinpocetine and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
Vinpocetine, a PDE1 modulator, regulates markers of cerebral health, inflammation, and oxidative stress in a rat model of prenatal alcohol-induced experimental attention deficit hyperactivity disorder.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Ethanol; Female; Humans; Interleukin-10; Interleukin-6; Oxidative Stress; Phosphoric Diester Hydrolases; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Tumor Necrosis Factor-alpha; Vinca Alkaloids | 2022 |
Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress.
Topics: Animals; Autism Spectrum Disorder; Behavior, Animal; Biomarkers; Disease Models, Animal; Doublecortin Protein; Female; Inflammation; Oxidative Stress; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Valproic Acid; Vinca Alkaloids | 2021 |
Embryo-fetal development studies with the dietary supplement vinpocetine in the rat and rabbit.
Topics: Abnormalities, Drug-Induced; Animals; Dietary Supplements; Embryonic Development; Female; Fetal Development; Fetal Weight; Fetus; Maternal Exposure; Pregnancy; Prenatal Exposure Delayed Effects; Rabbits; Rats; Rats, Sprague-Dawley; Vinca Alkaloids | 2018 |